Goldman Sachs Group Inc Emergent Bio Solutions Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 579,392 shares of EBS stock, worth $4.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
579,392
Previous 1,090,655
46.88%
Holding current value
$4.64 Million
Previous $5.3 Million
30.26%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding EBS
# of Institutions
188Shares Held
39.4MCall Options Held
299KPut Options Held
157K-
Black Rock Inc. New York, NY3.84MShares$30.7 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$28.9 Million2.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.58MShares$28.7 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.29MShares$18.3 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.85MShares$14.8 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $399M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...